News | December 20, 2006

FDA Clears New Thrombectomy System

The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra Thrombectomy System is the next-generation, re-engineered version of the company’s AngioJet Rheolytic Thrombectomy System.

AngioJet is marketed for blood clot removal (thrombectomy) from arterial and venous blood vessels. Possis says the new Ultra System features a simple and fast setup process, the flexibility to use a broad range of catheters, a sleeker design, lighter weight, and handling improvements that make it significantly easier to maneuver than the previous AngioJet drive unit.

Possis will conduct market evaluations of the Ultra System at key sites throughout the U.S. A full-market release is anticipated by Summer 2007.

AngioJet Systems are installed in 95 percent of top coronary labs in the U.S., according to a company release, with more than 1,700 systems are installed across the country. Possis currently estimates its total realizable market opportunity for AngioJet thrombectomy in the U.S. at $440 million, increasing to $675 million by 2010.

Related Content

Medtronic MindFrame Capture LP Revascularization Device Recalled.
News | Thrombectomy Devices | May 21, 2018
Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the...
Stryker Trevo Retriever Thrombectomy Device Approved for Stroke Treatment Up to 24 Hours
Technology | Thrombectomy Devices | February 15, 2018
The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo Retriever as a front-line...
Brain-scan guided emergency stroke treatment can save more lives
News | Thrombectomy Devices | January 25, 2018
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices | September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices | July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S.
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices | April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
SITS Open trial, mechanical thrombectomy devices. pREset, stroke treatment
News | Thrombectomy Devices | March 08, 2016
March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices | October 20, 2015
A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study
Feature | Thrombectomy Devices | September 02, 2015
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery...
Overlay Init